Amentoflavone inhibits iNOS, COX-2 expression and modulates cytokine profile, NF-κB signal transduction pathways in rats with ulcerative colitis

被引:107
作者
Sakthivel, K. M. [1 ]
Guruvayoorappan, C. [1 ]
机构
[1] Karunya Univ, Dept Biotechnol, Coimbatore 641114, Tamil Nadu, India
关键词
Amentoflavone; Acetic acid; Ulcerative colitis; Pro-inflammatory cytokines; Inducible nitric oxide synthase (iNOS); Cyclooxygenase-2 (COX-2); INFLAMMATORY-BOWEL-DISEASE; EXPERIMENTAL-MODELS; ACTIVATION; CELLS; FLAVONOIDS; INDUCTION; THERAPY; CANCER;
D O I
10.1016/j.intimp.2013.09.022
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Ulcerative colitis is a chronic inflammatory disorder characterized by oxidative stress, leucocyte infiltration and upregulation of pro-inflammatory cytokines. The aim of the present study was to examine the effect of amentoflavone on a murine model of ulcerative colitis (UC). UC was induced by intracolonic injection of 3% acetic acid in male Wistar rats. amentoflavone (10 mg/kg.b.wt) or reference drug sulfasalazine (100 mg/kg.b.wt) was administrated intra-peritoneally for 5 consecutive days before induction of colitis with acetic acid. Administration of amentoflavone was found to reduce the extent of inflammatory colonic injury. This was manifested by a decrease in the score of mucosal injury, by lowered colonic wet weight as well as vascular permeability and diminished lactate dehydrogenase (LDH) and myeloperoxidase (MPO) activity reflecting reduced leukocyte infiltration. Furthermore, the mucosal content of lipid peroxidation (LPO), glutathione (GSH), superoxide dismutase (SOD), nitric oxide (NO) activity confirms that amentoflavone could significantly inhibit colitis. The treatment also reduced significantly the colonic tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta) and IL-6 levels as well as the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) compared to colitis control group. The histopathological studies also confirm the foregoing findings. amentoflavone was also able to inhibit the activation and translocation of transcription factors, nuclear factor (NF)-kappa B subunits (p65/p50). These results suggest that amentoflavone exhibits protective effect in acetic acid-induced ulcerative colitis which might be due to its modulation of oxidant/anti-oxidant balance, downregulation of productions and expressions of pro-inflammatory cytokines, inflammatory mediators and inhibition of NF-kappa B signal transduction pathways. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:907 / 916
页数:10
相关论文
共 37 条
  • [1] Alzoghaibi Mohammed A, 2007, Saudi J Gastroenterol, V13, P187, DOI 10.4103/1319-3767.36750
  • [2] Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model
    Arafa, Hossam M. M.
    Hemeida, Ramadan A.
    El-Bahrawy, Ali I. M.
    Hamada, Farid M. A.
    [J]. FOOD AND CHEMICAL TOXICOLOGY, 2009, 47 (06) : 1311 - 1317
  • [3] Biologic therapy for inflammatory bowel disease
    Ardizzone, S
    Porro, GB
    [J]. DRUGS, 2005, 65 (16) : 2253 - 2286
  • [4] Inhibition of TNFα-induced cyclooxygenase-2 expression by amentoflavone through suppression of NF-κB activation in A549 cells
    Banerjee, T
    Valacchi, G
    Ziboh, VA
    van der Vliet, A
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2002, 238 (1-2) : 105 - 110
  • [5] Low detoxification capacity in the ileal pouch mucosa of patients with ulcerative colitis
    Berkhout, M
    Friederich, P
    van Krieken, JHJM
    Peters, WHM
    Nagengast, FM
    [J]. INFLAMMATORY BOWEL DISEASES, 2006, 12 (02) : 112 - 116
  • [6] Anti-inflammatory effects of methanol extract of Patrinia scabiosaefolia in mice with ulcerative colitis
    Cho, Eu-jin
    Shin, Ji-Sun
    Noh, Young-Su
    Cho, Young-Wuk
    Hong, Seung-Jae
    Park, Jae-Hoon
    Lee, Jae Yeol
    Lee, Jin-Yong
    Lee, Kyung-Tae
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2011, 136 (03) : 428 - 435
  • [7] Cholbi MR, 1991, EXPERIENTIA, V72, P153
  • [8] MAP kinases in inflammatory bowel disease
    Coskun, Mehmet
    Olsen, Jorgen
    Seidelin, Jakob Benedict
    Nielsen, Ole Haagen
    [J]. CLINICA CHIMICA ACTA, 2011, 412 (7-8) : 513 - 520
  • [9] EXPERIMENTAL-MODELS OF INFLAMMATORY BOWEL-DISEASE
    ELSON, CO
    SARTOR, RB
    TENNYSON, GS
    RIDDELL, RH
    [J]. GASTROENTEROLOGY, 1995, 109 (04) : 1344 - 1367
  • [10] ERICKSON RA, 1992, GASTROENTEROLOGY, V102, P1295